These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6663747)

  • 1. [Prevention and treatment of coronary lesions in Kawasaki disease. Treatment with anti-platelet agents and aspirin: optimum dosages and their evaluation].
    Shirahata A; Nakamura T; Asakura A
    Nihon Rinsho; 1983 Sep; 41(9):2103-10. PubMed ID: 6663747
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Kawasaki syndrome.
    Feigin RD; Barron KS
    N Engl J Med; 1986 Aug; 315(6):388-90. PubMed ID: 2426593
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of Kawasaki disease in the acute phase: steroid and aspirin therapy].
    Kato H; Ichinose E
    Nihon Rinsho; 1983 Sep; 41(9):2092-6. PubMed ID: 6663745
    [No Abstract]   [Full Text] [Related]  

  • 4. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
    De Rosa G; Pardeo M; Rigante D
    Eur Rev Med Pharmacol Sci; 2007; 11(5):301-8. PubMed ID: 18074939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood platelet disorders and thrombotic tendencies associated with Kawasaki disease].
    Yamada K
    Nihon Rinsho; 1983 Sep; 41(9):2097-102. PubMed ID: 6663746
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease].
    Suda K; Kudo Y; Sugawara Y; Ishii M; Matsuishi T
    Nihon Rinsho; 2008 Feb; 66(2):355-9. PubMed ID: 18265459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease: management guidelines.
    Nieves-Rivera F; Martin Pumarejo M; Villavicencio R
    Bol Asoc Med P R; 1988 Feb; 80(2):51-3. PubMed ID: 2450550
    [No Abstract]   [Full Text] [Related]  

  • 8. Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan.
    Tsuda E; Kawamata K; Neki R; Echigo S; Chiba Y
    Cardiol Young; 2006 Apr; 16(2):173-8. PubMed ID: 16553980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease with coronary artery aneurysm and symptomatic pneumonia.
    Managoli S; Chaturvedi P
    Indian Pediatr; 2003 Nov; 40(11):1106-7. PubMed ID: 14660853
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC; Aronoff SC
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kawasaki disease.
    Shulman ST; Bendet M
    Compr Ther; 1997 Jan; 23(1):13-8. PubMed ID: 9067077
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease.
    Koren G; Rose V; Lavi S; Rowe R
    JAMA; 1985 Aug; 254(6):767-9. PubMed ID: 4009911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of Kawasaki syndrome with intravenous gamma globulin.
    Newburger JW; Takahashi M; Burns JC; Beiser AS; Chung KJ; Duffy CE; Glode MP; Mason WH; Reddy V; Sanders SP
    N Engl J Med; 1986 Aug; 315(6):341-7. PubMed ID: 2426590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki disease. Epidemiology, late prognosis, and therapy.
    Barron KS
    Rheum Dis Clin North Am; 1991 Nov; 17(4):907-19. PubMed ID: 1767080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin.
    Ichida F; Fatica NS; Engle MA; O'Loughlin JE; Klein AA; Snyder MS; Ehlers KH; Levin AR
    Pediatrics; 1987 Dec; 80(6):828-35. PubMed ID: 3684392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin treatment and platelet function in Kawasaki disease.
    Yokoyama T; Kato H; Ichinose E
    Kurume Med J; 1980; 27(1):57-61. PubMed ID: 7382423
    [No Abstract]   [Full Text] [Related]  

  • 18. [The mucocutaneous lymph node syndrome (Kawasaki syndrome). A case with gallbladder hydrops and coronary artery aneurysm].
    Fritz ME; Giambonini S; Jenni R; D'Apuzzo V
    Schweiz Med Wochenschr; 1981 Apr; 111(16):566-71. PubMed ID: 7233135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of patients with a high risk of coronary artery aneurysm in Kawasaki disease: indication for immunoglobulin therapy.
    Nakano H
    Prog Clin Biol Res; 1987; 250():287-97. PubMed ID: 3423043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete Kawasaki disease: a pediatric diagnostic conflict.
    Celik U; Alhan E; Arabaci F
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):343-4. PubMed ID: 17785242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.